We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for public health professionals on immunisation.
The organisms that cause infectious diseases that laboratories must report, and how to report them.
Rotavirus immunisation information for public health professionals.
Historical vaccine development and introduction of vaccines in the UK.
Influenza vaccines marketed in the UK for 2024 to 2025, including ovalbumin content.
Guidance for public health professionals for the management of Shiga toxin-producing Escherichia coli (STEC) infection (including O157 and non-O157).
Flu vaccines available for the 2024 to 2025 flu season and the clinical risk groups that they apply to.
Information on taking, submitting and processing samples which potentially contain MPXV.
The characteristics, diagnosis and epidemiology of infections caused by spirochaetes of the genus Leptospira (Leptospires).
PGD template to support the national pertussis vaccination for pregnant women programme and vaccination of contacts of pertussis in accordance with guidelines.
Information for clinicians on the characteristics, diagnosis and epidemiology of infections caused by Chlamydia psittaci.
A guide to the human papillomavirus (HPV) vaccination programme, which became universal in September 2019.
Information for public health professionals about how vaccines work.
Description of scarlet fever, potential complications of the disease and advice on who's most at risk and how to prevent the spread.
Post exposure prophylaxis (PEP) is offered to individuals at high risk of severe chickenpox following an exposure.
Information on respiratory syncytial virus (RSV) and the benefits of vaccination for pregnant women and their babies and a poster and stickers to promote the vaccination to pregnant women.
Smallpox and mpox immunisation information for public health professionals.
This toolkit provides an outline of evidence-based antimicrobial stewardship in inpatient care settings.
Advice on staying well in cold weather, covering issues such as financial help, healthy lifestyle, flu vaccinations and heating.
Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).